APi Group Allowance for Doubtful Accounts Receivable (Current) increased by 14.3% to $16.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from $8.00M to $16.00M. Over 3 years (FY 2022 to FY 2025), Allowance for Doubtful Accounts Receivable (Current) shows an upward trend with a 67.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
A significant increase relative to receivables may signal deteriorating customer credit quality or economic headwinds in specific markets.
This is a contra-asset account representing the estimated amount of accounts receivable that the company expects will no...
Standard across all industries; peers in the medical device sector typically maintain low levels unless operating in high-risk emerging markets.
allowance_for_doubtful_accounts_receivable_current| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.00M | $4.00M | $5.00M | $5.00M | $6.00M | $4.00M | $9.00M | $8.00M | $13.00M | $15.00M | $14.00M | $16.00M |
| QoQ Change | — | +33.3% | +25.0% | +0.0% | +20.0% | -33.3% | +125.0% | -11.1% | +62.5% | +15.4% | -6.7% | +14.3% |
| YoY Change | — | — | +66.7% | — | — | +0.0% | +80.0% | +60.0% | +116.7% | +275.0% | +55.6% | +100.0% |